SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-054052
Filing Date
2018-10-16
Accepted
2018-10-16 17:01:50
Documents
3
Period of Report
2018-10-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv504917_8k.htm 8-K 18640
2 EXHIBIT 99.1 tv504917_ex99-1.htm EX-99.1 10135
3 GRAPHIC image_001.jpg GRAPHIC 7316
  Complete submission text file 0001144204-18-054052.txt   40227
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 181124904
SIC: 2834 Pharmaceutical Preparations